These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7719683)

  • 21. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
    Mauch PM; Canellos GP; Shulman LN; Silver B; Tarbell NJ; Come S; Rabin MS; Coleman CN
    J Clin Oncol; 1995 Apr; 13(4):947-52. PubMed ID: 7707123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined treatment strategy in over 200 children with Hodgkin's disease: graduated chemotherapy, involved field irradiation with low dosage and selective splenectomy. A report of the cooperative therapy study DAL-HD-82].
    Schellong G; Brämswig J; Ludwig R; Gerein V; Jobke A; Jürgens H; Kabisch H; Stollmann B; Weinel P; Gadner H
    Klin Padiatr; 1986; 198(3):137-46. PubMed ID: 3523020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment regimen for children and adolescents with Hodgkin's disease designed to decrease late complications of radiotherapy].
    Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Rokicka-Milewska R; Sopylo B; Kolakowska-Mrozowska B; Chybicka A; Boguslawska-Jaworska J; Pisarek J; Ras M; Sonta-Jakimczyk D; Janik-Moszant A; Kolecki P; Kaczmarek-Kanold M; Kowalczyk J; Odoj T; Matysiak M; Newecka-Samol T; Balcerska A; Adamkiewicz-Drozynska E; Wysocki M; Kurylak A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):25-35. PubMed ID: 12004149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation.
    Mauch P; Tarbell N; Weinstein H; Silver B; Goffman T; Osteen R; Zajac A; Coleman CN; Canellos G; Rosenthal D
    J Clin Oncol; 1988 Oct; 6(10):1576-83. PubMed ID: 3171625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity.
    Brusamolino E; Lunghi F; Orlandi E; Astori C; Passamonti F; Baraté C; Pagnucco G; Baio A; Franchini P; Lazzarino M; Bernasconi C
    Haematologica; 2000 Oct; 85(10):1032-9. PubMed ID: 11025593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of favorable early-stage hodgkin's lymphoma treatments: a single-institution review.
    Samant R; Alomary I; Alsaeed E; Al-Jasir B; Bence-Bruckler I; Cross P; Genest P; Huebsch L
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1166-70. PubMed ID: 19695788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
    McClain KL; Heise R; Day DL; Lee CK; Woods WG; Aeppli D
    Am J Pediatr Hematol Oncol; 1990; 12(2):147-54. PubMed ID: 1696073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
    Eich HT; Haverkamp U; Engert A; Kocher M; Skripnitchenko R; Brillant C; Sehlen S; Dühmke E; Diehl V; Müller RP
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):860-5. PubMed ID: 15925455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.
    Backstrand KH; Ng AK; Takvorian RW; Jones EL; Fisher DC; Molnar-Griffin BJ; Silver B; Tarbell NJ; Mauch PM
    J Clin Oncol; 2001 Feb; 19(3):736-41. PubMed ID: 11157025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involved field (IF) irradiation with or without chemotherapy in the management of children with Hodgkin's disease.
    Jereb B; Tan C; Bretsky S; He SQ; Exelby P
    Med Pediatr Oncol; 1984; 12(5):325-32. PubMed ID: 6493137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.
    Moinpour CM; Unger JM; Ganz PA; Kornblith AB; Gaynor ER; Bowers MA; Gatti GS; Kaminski MS; Erba HP; Wang T; Yoon J; Press OW; Fisher RI
    J Cancer Surviv; 2017 Feb; 11(1):32-40. PubMed ID: 27405732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation.
    Diamond DA; Michalski JM; Lynch JP; Trulock EP
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):795-800. PubMed ID: 9652840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease?
    Griffin T; Gerdes A; Parker R; Taylor E; Hafermann M; Taylor W; Tesh D
    Cancer; 1977 Dec; 40(6):2914-6. PubMed ID: 412583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiotherapy of Hodgkin's and non-Hodgkin's lymphomas. Indications, techniques and outcome].
    Engenhart-Cabillic R; Debus J; Wannenmacher M
    Radiologe; 1997 Jan; 37(1):81-8. PubMed ID: 9157480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can pelvic irradiation be omitted in patients with pathologic stages IA and IIA Hodgkin's disease?
    Goodman RL; Piro AJ; Hellman S
    Cancer; 1976 Jun; 37(6):2834-9. PubMed ID: 949703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy in the treatment of Hodgkin's disease.
    Timothy AR; Sutcliffe SB; Stansfeld AG; Wrigley PF; Jones AE
    Br Med J; 1978 May; 1(6122):1246-9. PubMed ID: 417751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.